Clinical Trials Directory
Recruiting
Conditions
Sponsors
Search
About
Trials
/
Sponsors
/ Acacia Pharma Ltd
Acacia Pharma Ltd
Industry · 18 registered clinical trials.
Status
Trial
Phase
Started
Completed
Study of Intravenous Amisulpride for Prophylaxis of Post-operative Nausea and Vomiting (PONV) in Pediatric Pat
Nausea and Vomiting, Postoperative
Phase 2 / Phase 3
2024-01-18
Withdrawn
Post Operative Nausea and Vomiting (PONV) Rescue Outcomes After Amisulpride Treatment
Nausea and Vomiting, Postoperative
—
2022-11-01
Active Not Recruiting
Investigation of Remimazolam in Children Undergoing Sedation for Medical Procedures
Pediatric ALL
Phase 2 / Phase 3
2021-11-15
Completed
PK Study of IV and Oral Amisulpride in Subjects With Severe Renal Impairment
Renal Disease, End Stage
Phase 1
2021-06-03
Completed
Study of APD421 With and Without Ondansetron
Postoperative Nausea and Vomiting
Phase 1
2018-07-17
Completed
Mass-balance Study of [14C]-APD421 in Healthy Volunteers
Post-operative Nausea and Vomiting
Phase 1
2016-08-01
Completed
Study of APD421 as PONV Treatment (Prior Prophylaxis)
Postoperative Nausea and Vomiting
Phase 3
2016-03-01
Completed
Study of APD421 as PONV Treatment (no Prior Prophylaxis)
Postoperative Nausea and Vomiting
Phase 3
2015-09-01
Completed
Phase IIIb Study of APD421 in Combination as PONV Prophylaxis
PONV
Phase 3
2015-02-01
Completed
Thorough QT Study of Intravenous Amisulpride
Healthy
Phase 1
2013-11-01
Completed
Dose-finding Study of APD403 to Prevent Nausea and Vomiting After Chemotherapy
CINV
Phase 2
2013-10-01
Completed
US Phase III Study of APD421 in PONV
PONV
Phase 3
2013-08-01
Completed
European Phase III Study of APD421 in PONV
PONV
Phase 3
2013-07-01
Completed
Phase II Dose-ranging Study of APD421 in PONV
Postoperative Nausea and Vomiting
Phase 2
2012-01-01
Completed
Proof-of-concept (PoC) Study of APD515
Xerostomia in Advanced Cancer Patients
Phase 2
2011-09-01
Completed
Phase II Proof-of-concept Study of APD421
Chemotherapy-induced Nausea and Vomiting
Phase 2
2011-02-01
Completed
Dose-ranging Study of APD405 in Post-operative Nausea and Vomiting (PONV)
Postoperative Nausea and Vomiting
Phase 2
2009-05-01
Completed
Pilot Study of APD209 in Cancer Cachexia
Cancer-related Cachexia
Phase 2
2009-03-01